NCT04662645
- Conditions
- Caregiver, Hemic and Lymphatic Diseases, Lung Diseases, +22 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Thymoma
Explore clinical trials studying Thymoma. Study availability and eligibility vary by location and protocol.
88 public trials
22 recruiting studies
Thymoma trial results
NCT00010257
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
- Locations
-
- Rush-Copley Cancer Care Center Aurora, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West Joliet, Illinois, United States
- Swedish-American Regional Cancer Center Rockford, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital Urbana, Illinois, United States
Completed
Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
NCT00003283
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
- Locations
-
- Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
- Stanford University Medical Center Stanford, California, United States
- CCOP - Colorado Cancer Research Program, Inc. Denver, Colorado, United States
- Sylvester Cancer Center, University of Miami Miami, Florida, United States
NCT04430842
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
- Locations
-
- St George Private Hospital Kogarah, New South Wales, Australia
- Sydney Southwest Private Hospital Liverpool, New South Wales, Australia
NCT03517488
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
- Locations
-
- Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
- UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
- University of California San Diego Moores Cancer Center San Diego, California, United States
- University of California San Francisco Medical Center San Francisco, California, United States
Completed
Nonmyeloablative Allogeneic Transplant
NCT01272817
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adenocarcinoma, +91 more
- Locations
-
- Scripps Green Hospital La Jolla, California, United States
Completed
Surgery for Masaoka-Koga I-II Thymoma
NCT05001113
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Masaoka Stage I, +8 more
- Locations
-
- Shanghai Zhongshan Hospital Shanghai, China
Completed
Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy
NCT02307500
- Conditions
- Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, +39 more
- Locations
-
- Istituto Clinico Humanitas Rozzano, Milan, Italy
NCT02049047
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
- Locations
-
- Istituto Clinico Humanitas Rozzano, MI, Italy
NCT03102320
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +28 more
- Locations
-
- Mayo Clinic Hospital Phoenix, Arizona, United States
- University of Southern California Los Angeles, California, United States
- Stanford Health Care Stanford, California, United States
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States